Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease

References

• Uddin MS, Kabir MT, Al Mamun A, et al. APOE and Alzheimer’s disease: evidence mounts that targeting APOE4 may combat Alzheimer’s pathogenesis. Mol Neurobiol. 2019 Apr 1;56(4):2450–2465.
   PubMed Web of Science ®Google Scholar
• Hossain MF, Uddin MS, Uddin GMS, et al. Melatonin in Alzheimer’s disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer’s Neuropathology. Mol Neurobiol. 2019 Dec 1;56(12):8255–8276.
   PubMed Web of Science ®Google Scholar
• Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007 Feb;8(2):101–112. PMID: 17245412. doi:10.1038/nrm2101.
   PubMed Web of Science ®Google Scholar
• Tripathi T, Kalita P. Synergistic effect of amyloid-β and tau disrupts neural circuits. ACS Chem Neurosci. 2019 MarJan 2031;10(3):1129–1130. DOI:10.1021/acschemneuro.9b00037. Epub 2019.
   PubMed Web of Science ®Google Scholar
• Atri A. Current and future treatments in Alzheimer’s disease. Semin Neurol [Internet]. 2019 [cited 2023 Mar 20];39(2):227–240. Available from: https://pubmed.ncbi.nlm.nih.gov/30925615/.
   PubMed Web of Science ®Google Scholar
• Krupp MA, Chatton MJ. Current medical diagnosis & treatment?. J Clin Gastroenterol. 1983;5(5):479.
   Google Scholar
• Uddin MS, Tewari D, Mamun AA, et al. Circadian and sleep dysfunction in Alzheimer’s disease. Ageing Res Rev. 2020 Jul 1;60:101046.
   PubMed Web of Science ®Google Scholar
• Mccleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in Alzheimer’s disease. Cochrane Database Syst Rev. 2014 Mar 21;2014(3):CD009178. DOI:10.1002/14651858.CD009178.pub2
   Google Scholar
• Lv YN, Cui Y, Zhang B, et al. Sleep deficiency promotes Alzheimer’s disease development and progression. Front Neurol. 2022 Dec 14;13: 1053942. DOI:10.3389/fneur.2022.1053942.
   PubMed Web of Science ®Google Scholar
• Szeto JYY, Lewis SJG. Current treatment options for Alzheimer’s disease and Parkinson’s disease dementia. Curr Neuropharmacol. 2016 Apr 18;14(4):326–338.
   PubMed Web of Science ®Google Scholar
• Chong MS, Ayalon L, Marler M, et al. Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer’s disease with sleep disordered breathing. J Am Geriatr Soc. 2006;54(5):777–781. DOI:10.1111/j.1532-5415.2006.00694.x
   PubMed Web of Science ®Google Scholar
• Cooke JR, Ancoli-Israel S, Liu L, et al. Continuous positive airway pressure deepens sleep in patients with Alzheimer’s disease and obstructive sleep apnea. Sleep Med [Internet]. 2009;10(10):1101–1106. DOI:10.1016/j.sleep.2008.12.016
   PubMed Web of Science ®Google Scholar
• Nascimento CMC, Ayan C, Cancela JM, et al. Effect of a multimodal exercise program on sleep disturbances and instrumental activities of daily living performance on Parkinson’s and Alzheimer’s disease patients. Geriatr Gerontol Int. 2014;14(2):259–266.
   PubMed Web of Science ®Google Scholar
• Figueiro MG, Plitnick B, Roohan C, et al. Effects of a tailored lighting intervention on sleep quality, rest–activity, mood, and behavior in older adults with Alzheimer disease and related dementias: a randomized clinical trial. J Clin Sleep Med. 2019;15(12):1757–1767. DOI:10.5664/jcsm.8078
   PubMed Web of Science ®Google Scholar
• Dowling GA, Burr RL, Van Someren EJW, et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s disease. J Am Geriatr Soc [Internet]. 2008 Feb [cited 2022 Mar 30];56(2):239–246. Available from: https://pubmed.ncbi.nlm.nih.gov/18070004/.
   PubMed Web of Science ®Google Scholar
• Gfigueiro MG, Plitnick BA, Lok A, et al. Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities. Clin Interv Aging. 2014 Sep 12;9:1527–1537.
   PubMed Web of Science ®Google Scholar
• McCurry SM, Pike KC, Vitiello MV, et al. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: results of a randomized, controlled trial. J Am Geriatr Soc. 2011;59(8):1393–1402.
   PubMed Web of Science ®Google Scholar
• Fontana Gasio P, Kräuchi K, Cajochen C, et al. Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly. Exp Gerontol. 2003;38(1–2):207–216. DOI:10.1016/S0531-5565(02)00164-X
   PubMed Web of Science ®Google Scholar
• Burns A, Allen H, Tomenson B, et al. Bright light therapy for agitation in dementia: a randomized controlled trial. Int Psychogeriatrics. 2009;21(4):711–721.
   PubMed Web of Science ®Google Scholar
• Wade AG, Farmer M, Harari G, et al. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clin Interventions Aging. 2014;9:947–961. Available from: https://pubmed.ncbi.nlm.nih.gov/24971004/
   PubMed Web of Science ®Google Scholar
• Singer C, Tractenberg RE, Kaye J, et al. Alzheimer’s disease cooperative study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep. 2003 Nov 1;26(7):893–901. PMID: 14655926; PMCID: PMC4418658. DOI:10.1093/sleep/26.7.893
   PubMed Web of Science ®Google Scholar
• Serfaty M, Kennell-Webb S, Warner J, et al. Double blind randodmised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry. 2002;17(12):1120–1127.
   PubMed Web of Science ®Google Scholar
• Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in Alzheimer’s disease. Am J Psychiatry. 1981;138(7):970–972.
   PubMed Web of Science ®Google Scholar
• Study P, Poyares D, Sukys-Claudino L. Donepezil Improves obstructive sleep apnea in Alzheimer disease *. Chest. 2008;133(3):677–683.
   PubMed Web of Science ®Google Scholar
• Safety and efficacy of lemborexant for sleep-wake regulation in patients with irregular sleep wake rhythm disorder and Alzheimer’s disease dementia | Cochrane library [Internet]. [cited 2021 Jul 17]. Available from: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01935466/full
   Google Scholar
• Stahl SM, Markowitz JS, Papadopoulos G, et al. Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer’s disease. Curr Med Res Opin. 2004;20(4):517–524.
   PubMed Web of Science ®Google Scholar
• Grippe TC, Gonçalves BSB, Louzada LL, et al. Circadian rhythm in Alzheimer disease after trazodone use. Chronobiol Int. 2015;32(9):1311–1314. DOI:10.3109/07420528.2015.1077855
   PubMed Web of Science ®Google Scholar
• Camargos EF, Louzada LL, Quintas JL, et al. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry [Internet]. 2014;22(12):1565–1574. DOI: 10.1016/j.jagp.2013.12.174
   PubMed Web of Science ®Google Scholar
• Kouzuki M, Kitao S, Kaju T, et al. Evaluation of the effect of aroma oil as a bath salt on cognitive function. 2020 Mar 1 [cited 2021 Jul 11];20(2):163–171. DOI:10.1111/psyg.12481
   Google Scholar
• Rose KM, Taylor AG, Bourguignon C. Effects of cranial electrical stimulation on sleep disturbances, depressive symptoms, and caregiving appraisal in spousal caregivers of persons with Alzheimer’s disease. Appl Nurs Res [Internet]. 2009;22(2):119–125. DOI:10.1016/j.apnr.2007.06.001
   PubMed Web of Science ®Google Scholar
• Markowitz JS, Gutterman EM, Lilienfeld S, et al. Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. Sleep [Internet]. 2003 Aug 1 [cited 2021 Jul 14];26(5):602–606. DOI:10.1093/sleep/26.5.602
   PubMed Web of Science ®Google Scholar
• Scoralick FM, Louzada LL, Quintas JL, et al. Mirtazapine does not improve sleep disorders in Alzheimer’s disease: results from a double-blind, placebo-controlled pilot study. Psychogeriatrics. 2017;17(2):89–96.
   PubMed Web of Science ®Google Scholar
• Meguro K, Meguro M, Tanaka Y, et al. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer’s disease. 2004 Jun [cited 2021 Jul 14];17(2):61–67. DOI:10.1177/0891988704264535
   Google Scholar
• Herring WJ, Ceesay P, Snyder E, et al. Polysomnographic assessment of suvorexant in patients with probable Alzheimer’s disease dementia and insomnia: a randomized trial. Alzheimers Dement [Internet]. 2020 Mar 1 [cited 2021 Jul 11];16(3):541–551. Available from: https://pubmed.ncbi.nlm.nih.gov/31944580/
   PubMed Web of Science ®Google Scholar
• Savaskan E, Schnitzler C, Schröder C, et al. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer’s disease: haloperidol vs. quetiapine. Int J Neuropsychopharmacol. 2006 Oct;9(5):507–516.
   PubMed Web of Science ®Google Scholar
• Ito T, Yamadera H, Ito R, et al. Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in Alzheimer-type dementia. Psychiatry Clin Neurosci [Internet]. 2001 [cited 2021 Jul 17];55(3):281–282. DOI:10.1046/j.1440-1819.2001.00860.x
   PubMed Web of Science ®Google Scholar
• Cooke JR, Loredo JS, Liu L, et al. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer’s disease. Drugs Aging. 2006;23(6):503–511. DOI:10.2165/00002512-200623060-00005
   PubMed Web of Science ®Google Scholar
• Cooke JR, Ayalon L, Palmer BW, et al. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer’s disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med [Internet]. 2009 Jul 14 [cited 2021 Aug 15];5(4):305–309. Available from: https://pubmed.ncbi.nlm.nih.gov/19968005/.
   PubMed Web of Science ®Google Scholar
• Skjerve A, Holsten F, Aarsland D, et al. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia. Psychiatry Clin Neurosci [Internet]. 2004 Aug [cited 2022 Mar 30];58(4):343–347. Available from: https://pubmed.ncbi.nlm.nih.gov/15298644/
   PubMed Web of Science ®Google Scholar
• Yamadera H, Ito T, Suzuki H, et al. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci. 2000;54(3):352–353.
   PubMed Web of Science ®Google Scholar
• Mizuno S, Kameda A, Inagaki T, et al. Effects of donepezil on Alzheimer’s disease: the relationship between cognitive function and rapid eye movement sleep. Psychiatry Clin Neurosci [Internet]. 2004 Dec [cited 2021 Jul 14];58(6):660–665. Available from: https://pubmed.ncbi.nlm.nih.gov/15601392/
   PubMed Web of Science ®Google Scholar
• Mishima K, Okawa M, Hishikawa Y, et al. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand. 1994;89(1):1–7.
   PubMed Web of Science ®Google Scholar
• Sekiguchi H, Iritani S, Fujita K. Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer’s type dementia: a case series. Psychogeriatrics. 2017 Sep 1;17(5):275–281.
   PubMed Web of Science ®Google Scholar
• La AL, Walsh CM, Neylan TC, et al. Long-term trazodone use and cognition: a potential therapeutic role for slow-wave sleep enhancers. J Alzheimer’s Dis. 2019;67(3):911–921. DOI:10.3233/JAD-181145
   PubMed Web of Science ®Google Scholar
• Brusco LI, Fainstein I, Márquez M, et al. Effect of melatonin in selected populations of sleep-disturbed patients. Neurosignals. 1999;8(1–2):126–131.
   Google Scholar
• Bromundt V, Wirz-Justice A, Boutellier M, et al. Effects of a dawn-dusk simulation on circadian rest-activity cycles, sleep, mood and well-being in dementia patients. Exp Gerontol. 2019 Sep 1;124:110641.
   PubMed Web of Science ®Google Scholar
• Katsunuma H, Shimizu T, Ogawa K, et al. Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer’s disease and Parkinson’s disease. Psychiatry Clin Neurosci [Internet]. 1998 [cited 2021 Jul 17];52(2):198–200. DOI:10.1111/j.1440-1819.1998.tb01028.x
   PubMed Web of Science ®Google Scholar
• Shih YH, Wang JJ, Shih YH, et al. Sundown syndrome, sleep quality, and walking among community-dwelling people with Alzheimer disease. J Am Med Dir Assoc [Internet]. 2017;18(5):396–401. DOI:10.1016/j.jamda.2016.10.016
   PubMed Web of Science ®Google Scholar
• Niitsu T, Okamoto H, Iyo M. Behavioural and psychological symptoms of dementia in an Alzheimer’s disease case successfully treated with natural medicine: association with gonadotropins. Psychogeriatrics. 2013 Jun;13(2):124–127.
   PubMed Web of Science ®Google Scholar
• Anderson KN, Jamieson S, Graham AJ, et al. REM sleep behaviour disorder treated with melatonin in a patient with Alzheimer’s disease. Clin Neurol Neurosur. 2008 May;110(5):492–495.
   PubMed Web of Science ®Google Scholar
• Simoncini M, Gatti A, Quirico PE, et al. Acupressure in insomnia and other sleep disorders in elderly institutionalized patients suffering from Alzheimer’s disease. Aging Clin Exp Res. 2015 Feb 1;27(1):37–42.
   PubMed Web of Science ®Google Scholar
• Homolak J, Mudrovčić M, Vukić B, et al. Circadian Rhythm and Alzheimer’s disease. Med Sci (Basel). 2018 Jun 21;6(3):52. DOI:10.3390/medsci6030052
   PubMedGoogle Scholar
• Van Erum J, Van Dam D, De Deyn PP. Alzheimer’s disease: neurotransmitters of the sleep-wake cycle. Neurosci Biobehav Rev. 2019 OctAug;105:72–80. [Epub 2019 1]. DOI:10.1016/j.neubiorev.2019.07.019
   PubMed Web of Science ®Google Scholar
• Bartus RT, Dean RL 3rd, Beer B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982 Jul 30;217(4558):408–414.
   PubMed Web of Science ®Google Scholar
• Michelsen KA, Prickaerts J, Steinbusch HW. The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer’s disease. Prog Brain Res. 2008;172:233–264.
   PubMed Web of Science ®Google Scholar
• Wang C, Holtzman DM. Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors. Neuropsychopharmacology. 2020 Jan;45(1):104–120.
   PubMed Web of Science ®Google Scholar
• Mendelsohn AR, Larrick JW. Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and Neurodegenerative diseases. Rejuvenation Res. 2013 Dec 1;16(6):518–523.
   PubMed Web of Science ®Google Scholar
• Wu YH, Swaab DF. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer’s disease. Sleep Med. 2007 Sep;8(6):623–636.
   PubMed Web of Science ®Google Scholar
• Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373–377. DOI:10.1126/science.1241224
   PubMed Web of Science ®Google Scholar
• Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012 Aug 15;4(147). DOI:10.1126/scitranslmed.3003748
   PubMed Web of Science ®Google Scholar
• Louzada LL, Machado FV, Quintas JL, et al. The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer’s disease: a randomized, triple-blind, placebo-controlled trial. Neuropsychopharmacology. 2022 Jan;47(2):570–579. Epub 2021 Oct 11. PMID: 34635802; PMCID: PMC8674235. DOI:10.1038/s41386-021-01191-3
   PubMed Web of Science ®Google Scholar
• Huo S, Cheng L, Li S, et al. Effects of eszopiclone on sleep quality and cognitive function in elderly patients with Alzheimer’s disease and sleep disorder: a randomized controlled trial. Brain Behav. 2022 Feb;12(2):e2488. Epub 2022 Jan 18. PMID: 35041261; PMCID: PMC8865158. DOI:10.1002/brb3.2488
   PubMed Web of Science ®Google Scholar
• Dowling GA, Hubbard EM, Mastick J, et al. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer’s disease. Int Psychogeriatrics. 2005;17(2):221–236.
   PubMed Web of Science ®Google Scholar
• Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev [Internet]. 2011 Apr [cited 2022 Apr 16];15(2):99–106. Available from: https://pubmed.ncbi.nlm.nih.gov/20965131/
   PubMed Web of Science ®Google Scholar
• Cao H, Pan X, Li H, et al. Acupuncture for treatment of insomnia: a systematic review of randomized controlled trials. J Altern Complement Med [Internet]. 2009 Nov 1 [cited 2022 Apr 16];15(11):1171–1186. DOI:10.1089/acm.2009.0041
   PubMed Web of Science ®Google Scholar
• Chen ML, Lin LC, Wu SC, et al. The effectiveness of acupressure in improving the quality of sleep of institutionalized residents. J Gerontol A Biol Sci Med Sci. 1999 [cited 2022 Apr 16];54(8):M389–394. DOI:10.1093/gerona/54.8.M389
   PubMed Web of Science ®Google Scholar
• Zhou X, Wang Y, Lv S, et al. Transcranial magnetic stimulation for sleep disorders in Alzheimer’s disease: a double-blind, randomized, and sham-controlled pilot study. Neurosci Lett. 2022 Jan 1;766:136337. DOI:10.1016/j.neulet.2021.136337. Epub 2021 Nov 8. PMID: 34762980.
   PubMed Web of Science ®Google Scholar
• Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev [Internet]. 2006 [cited 2022 May 1];2006(1). Available from: https://pubmed.ncbi.nlm.nih.gov/16437532/
   PubMedGoogle Scholar
• Raphelson JR, Kreitinger KY, Malhotra A. Positive airway pressure therapy in sleep-disordered breathing. Neurotherapeutics [Internet]. 2021 Jan 1;18(1):75 [cited 2022 May 1]. DOI:10.1007/s13311-020-00971-x
   PubMed Web of Science ®Google Scholar
• van Maanen A, Meijer AM, van der Heijden KB, et al. The effects of light therapy on sleep problems: a systematic review and meta-analysis. Sleep Med Rev [Internet]. 2016 Oct 1 [cited 2022 May 1];29:52–62. DOI:10.1016/j.smrv.2015.08.009
   PubMed Web of Science ®Google Scholar
• Roland JP, Bliwise DL. Impact of pharmacotherapy on insomnia in patients with Alzheimer’s disease. Drugs And Aging [Internet]. 2021;38(11):951–966. DOI:10.1007/s40266-021-00891-1
   PubMed Web of Science ®Google Scholar